Experimental vaccine aims to tame silent hepatitis b infection

NCT ID NCT04684914

Summary

This study tested whether a new vaccine called HepTcell could help the body's immune system fight chronic hepatitis B in people who weren't taking medication for it. Researchers gave the vaccine or a placebo to 87 adults with inactive hepatitis B to see if it reduced virus levels in their blood. The trial was stopped early and did not complete its planned testing.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATITIS B, CHRONIC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Central Sooner Research

    Oklahoma City, Oklahoma, 73071, United States

  • Consorcio Hospital General Universitario De Valencia

    Valencia, 46014, Spain

  • Goethe University Hospital

    Frankfurt am Main, 60590, Germany

  • Hospital Clínic De Barcelona

    Barcelona, 08028, Spain

  • Hospital Nuestra Señora De Valme

    Seville, 41014, Spain

  • Hospital Universitari I Politècnic La Fe

    Valencia, 46026, Spain

  • Hospital Universitari Vall D'Hebron

    Barcelona, 08035, Spain

  • Hospital Universitario La Paz

    Madrid, 28046, Spain

  • Kansas City Research Institute

    Kansas City, Missouri, 64131, United States

  • Paragon Rx Clinical

    Garden Grove, California, 92840, United States

  • Queens Medical Center

    Nottingham, NG7 2UH, United Kingdom

  • San Jose Gastroenterology Institute

    San Jose, California, 95128, United States

  • St. Georges University of London

    London, SW17 0RE, United Kingdom

  • St. Mary's Hospital

    London, W2 1NY, United Kingdom

  • Stanford University Department of Medicine

    Redwood City, California, 94063, United States

  • The Ottawa Hospital

    Ottawa, Ontario, K1H 8L6, Canada

  • Toronto Centre for Liver Disease (TCLD), Toronto General Hospital, UHN

    Toronto, Ontario, M5G 2C4, Canada

  • Toronto Liver Centre

    Toronto, Ontario, M6H 3M1, Canada

  • University of Alberta Hospital

    Edmonton, Alberta, T6G 2G3, Canada

  • University of Calgary Liver Unit - Heritage Medical Research Clinic

    Calgary, Alberta, T2N 4Z6, Canada

  • Univesritätsklinikum Hamburg-Eppendorf

    Hamburg, 20246, Germany

Conditions

Explore the condition pages connected to this study.